title: Utility of faecal calprotectin analysis in adult inflammatory bowel disease.
abstract: The inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are chronic relapsing, remitting disorders. Diagnosis, along with assessment of disease activity and prognosis present challenges to managing clinicians. Faecal biomarkers, such as faecal calprotectin, are a non-invasive method which can be used to aid these decisions. Calprotectin is a calcium and zinc binding protein found in the cytosol of human neutrophils and macrophages. It is released extracellularly in times of cell stress or damage and can be detected within faeces and thus can be used as a sensitive marker of intestinal inflammation. Faecal calprotectin has been shown to be useful in the diagnosis of IBD, correlates with mucosal disease activity and can help to predict response to treatment or relapse. With growing evidence supporting its use, over the last decade this faecal biomarker has significantly changed the way IBD is managed.
authors.affiliation: Inflammatory Bowel Diseases Service, Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow G4 0SF, United Kingdom.
authors.forename: Lyn A
authors.initials: LA
authors.lastname: Smith
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Gaya
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces; D005786:Gene Expression Regulation; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000378:metabolism*; D039841:Leukocyte L1 Antigen Complex / Q000378:metabolism*; D009092:Mucous Membrane / Q000378:metabolism; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex